Dental Doctor Initiates IPO Process on Shanghai Stock Exchange; Arrail Group Records 1.973 Million Patient Visits in FY2026; Oral Intern Doctor Sentenced to 1.5 Years for Unlicensed Tooth Extraction …

Dental Doctor Initiates IPO Process on Shanghai Stock Exchange

On May 29, 2026, Dental Doctor Medical Holding Group signed an IPO guidance agreement with Dongwu Securities Co., Ltd. and submitted an IPO guidance filing to the Shanghai Stock Exchange. The company has achieved a cumulative net profit of 323 million yuan, operating revenue of 4.665 billion yuan, and cumulative operating cash flow of 841 million yuan over the past three years, meeting the listing rules of the Shanghai Stock Exchange. It has deployed 41 direct-operated dental institutions across 15 cities in East China, planning to invest no more than 200 million yuan to add approximately 5 new institutions and build a headquarters hospital. The company does not have any negative listing circumstances, and relevant review and issuance risks have been disclosed to investors.

Arrail Group Records 1.973 Million Patient Visits in FY2026; Independent Investigation Report Expected by End of July

On June 1, 2026, Arrail Group disclosed operations of 111 dental service points in Mainland China, equipped with 1,483 dental chairs, serving approximately 1.973 million patient visits annually. The independent investigation has entered the final interview stage, with a draft report expected to be released by the end of July 2026. The group employs 1,010 dentists, with an average of 1,325 patient visits per dental chair per year. As of the announcement, the group has 3,167 full-time employees. The company's shares have been suspended from trading since December 1, 2025.

Unlicensed Dental Intern Sentenced to 1.5 Years for Fatal Extraction; Clinic and Individual to Pay 370,000 Yuan in Compensation

On June 3, 2026, the Longhua District Court in Haikou concluded an illegal medical practice case. Intern dentist Huang Moucheng, lacking a practice license, performed an unauthorized tooth extraction resulting in a patient's death. The court sentenced him to one year and six months in prison, suspended for two years, and fined him 20,000 yuan. Through mediation, Huang personally compensated 200,000 yuan, and the dental clinic where he worked paid 170,000 yuan, totaling 370,000 yuan. The court emphasized that medical institutions must strictly manage employment, and patients should verify practitioner qualifications and choose legitimate facilities.

Guangxi Medical Insurance Bureau Proposes Integration of 37 Surgical Assistance Pricing; "Intraoperative Microscopic Imaging Assistance Fee" Set at 307 Yuan per Procedure

On June 2, 2026, the Guangxi Zhuang Autonomous Region Medical Security Bureau released a draft proposal clarifying that the "Intraoperative Microscopic Imaging Assistance Fee" at tertiary public medical institutions is tentatively priced at 307.00 yuan per procedure, and the "Micro-motor assisted procedure fee" at tertiary public hospitals is set at 170 yuan per procedure. The proposal also published fee standards for digital surgical assistance projects, including oral 3D modeling at 280 yuan per procedure, medical 3D Model Printing at 450 yuan per piece, and guide plate printing at 1,033 yuan per piece. The document also requires institutions to save and upload medical data and equipment operation records; failure to provide data will result in a 100 yuan reduction per item.

TOPCHOICE MEDICAL CORPORATION Plans 50-100 Million Yuan Share Buyback for Cancellation; Five Senior Executives Previously Disclosed Share Purchase Plans

On June 4, 2026, TOPCHOICE MEDICAL CORPORATION announced a plan to repurchase shares worth 50 million to 100 million yuan within 12 months at a price not exceeding 60.12 yuan per share, representing approximately 0.04% to 0.08% of total share capital. All repurchased shares will be canceled to reduce registered capital. Previously, five senior executives had increased their holdings by 6 million to 12 million yuan. The buyback funds account for approximately 0.8% of the company's total assets and about 1.13% of its net assets. The board of directors unanimously approved the plan, which still requires shareholder approval.

Lone Peak, One of the Largest Pediatric Dental DSOs in the U.S., Secures Approximately 101 Million Yuan in Mezzanine Financing

On June 2, 2026, Atlanta-based investment firm o15 Capital Partners provided $15 million (approximately 101 million yuan) in mezzanine debt financing to Lone Peak Dental Group, a U.S. pediatric dental DSO. Founded in 2003, Lone Peak operates 73 clinics across 14 states, employing over 150 dentists and with 81% bilingual staff. This funding represents its second round of capital injection, aimed at accelerating mergers and acquisitions and operational growth, thereby improving oral services for low-income children. As of press time, Lone Peak has not disclosed its latest post-financing valuation or target acquisition list.

Swiss Dental MedTech Company vVARDIS Prepares for U.S. IPO, Expected to Complete by 2026

On June 2, 2026, Swiss dental MedTech company vVARDIS Holding AG announced it has hired JPMorgan Chase and Goldman Sachs as underwriters, planning to complete its U.S. IPO within 2026. Its core product, Curodont™, is used in approximately 20% of U.S. dental clinics, having treated around 3 million teeth cumulatively. In April 2026, Apollo Global Management completed a minority equity investment, pushing the company's valuation to over $1 billion. Data from the U.S. Centers for Disease Control and Prevention indicates that approximately 90% of U.S. adults have experienced dental caries.

Shanghai Stomatological Hospital and University of Hong Kong Faculty of Dentistry Sign MOU, Establish Oral Innovation Materials Expert Committee

From May 22 to 23, the Shanghai Stomatological Hospital and the Faculty of Dentistry at the University of Hong Kong held the "Shanghai-Hong Kong Dental Summit: 2026 Future Oral Biomaterials Frontier Forum" in Shanghai. They signed a memorandum of understanding and established the "Oral Innovation Materials Expert Committee" as a sub-center of the National Key Laboratory of Polymer Molecular Engineering for Oral Medicine. The inaugural members come from 13 institutions, including the Peking University School of Stomatology. This marks the fourth edition of the forum.

World First: Four Japanese Companies Launch Dental Zirconia Waste Recycling Project, Aiming for Commercialization by 2028

On May 21, 2026, four companies—Shofu, Tosoh, Mitsui Chemicals, and Orbray—launched a verification project for recycling dental Zirconia waste, aiming to address the issue of approximately 80% material waste during processing. Shofu is responsible for collecting waste, Tosoh uses Zirconia Refine technology for regeneration, Orbray shapes the regenerated powder into Zirconia blocks, and Mitsui Chemicals provides operational support. The project plans to achieve commercial application after completing verification in fiscal year 2028.

Spain Allocates Approximately 470 Million Yuan to Expand Public Dental Care Coverage

On May 26, 2026, the Spanish Cabinet authorized the allocation of 60.058 million euros (approximately 473 million yuan) to expand public dental care within the National Health System, focusing on children and adolescents aged 0-14, pregnant women, and people with disabilities. This policy increases oral care coverage for children aged 0-14 to 30.4% and for pregnant women to 25%. On the same day, 172 million euros (approximately 1.356 billion yuan) was approved for the modernization of primary care facilities.

Total of $2.3 Million: One of the Largest Dental DSOs in the U.S. Fined for Interfering in Clinic Operations

On May 7, 2026, California Attorney General Rob Bonta announced a settlement with Aspen Dental Management, Inc. for violating California's corporate practice of dentistry prohibition and publishing misleading advertisements. The company was fined $2 million and ordered to pay $300,000 in restitution, along with implementing several restrictive measures. Founded in 1998, Aspen Dental is one of the largest dental DSOs in the U.S., entering California in 2019 with 19 clinics. In 2024, the company paid $3.5 million to settle a case in Massachusetts regarding telemarketing and false advertising.

UK Dental Complaints Hit Five-Year High in 2025; Orthodontics and Clinical Examinations Become High-Risk Compliance Areas for Practitioners

On June 3, 2026, the UK dental regulatory body GDC released its "2025 Fitness to Practise Statistical Report," stating that 1,766 new complaints were filed in 2025, a 26% increase year-on-year, marking a five-year high. Orthodontic examinations accounted for 15% of clinical allegations, and the average processing time for cases in the assessment stage extended from 76 weeks in 2024 to 78 weeks. The GDC stated it aims to enhance transparency, optimize investigation processes, and improve support mechanisms for participants to reduce additional procedural pressure while ensuring patient safety.

New Study: Chronic Oral Inflammation May Damage Ovarian Immune Environment, Reducing Fertility

In April 2026, an animal study published in the "Journal of Dental Research" showed that chronic oral inflammation damages mouse ovaries through systemic immune regulation, leading to a decrease in follicle count and egg quality, with the experimental group's birth rate significantly lower than the control group. The study, conducted by a team including Michael Klutstein from the Hebrew University of Jerusalem, suggests that oral inflammation may be a potential risk factor for female infertility. The researchers emphasized that the results are limited to mice and require clinical trials for verification.